DnB Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.7M Sell
86,931
-89,600
-51% -$39.9M 0.16% 100
2025
Q1
$85.6M Sell
176,531
-24,411
-12% -$11.8M 0.39% 52
2024
Q4
$80.9M Buy
200,942
+19,289
+11% +$7.77M 0.35% 45
2024
Q3
$84.5M Buy
181,653
+14,931
+9% +$6.94M 0.38% 47
2024
Q2
$78.1M Sell
166,722
-24,528
-13% -$11.5M 0.37% 48
2024
Q1
$79.9M Sell
191,250
-7,168
-4% -$3M 0.42% 41
2023
Q4
$80.7M Buy
198,418
+6,211
+3% +$2.53M 0.42% 44
2023
Q3
$66.8M Sell
192,207
-16,398
-8% -$5.7M 0.4% 50
2023
Q2
$73.4M Sell
208,605
-75,042
-26% -$26.4M 0.42% 51
2023
Q1
$89.4M Sell
283,647
-16,116
-5% -$5.08M 0.57% 38
2022
Q4
$86.6M Sell
299,763
-16,219
-5% -$4.68M 0.61% 32
2022
Q3
$91.5M Sell
315,982
-29,221
-8% -$8.46M 0.71% 25
2022
Q2
$97.3M Sell
345,203
-6,275
-2% -$1.77M 0.68% 30
2022
Q1
$91.7M Sell
351,478
-136,417
-28% -$35.6M 0.55% 37
2021
Q4
$107M Sell
487,895
-22,007
-4% -$4.83M 0.63% 29
2021
Q3
$92.5M Buy
509,902
+86,593
+20% +$15.7M 0.6% 29
2021
Q2
$85.4M Buy
423,309
+349,530
+474% +$70.5M 0.57% 28
2021
Q1
$15.9M Buy
73,779
+35,326
+92% +$7.59M 0.12% 140
2020
Q4
$9.09M Buy
38,453
+3,718
+11% +$879K 0.08% 186
2020
Q3
$9.45M Buy
34,735
+2,575
+8% +$701K 0.1% 151
2020
Q2
$9.34M Buy
32,160
+5,256
+20% +$1.53M 0.11% 144
2020
Q1
$6.4M Sell
26,904
-5,238
-16% -$1.25M 0.09% 159
2019
Q4
$7.04M Buy
32,142
+4,397
+16% +$963K 0.07% 196
2019
Q3
$4.7M Buy
27,745
+1,944
+8% +$329K 0.05% 250
2019
Q2
$4.73M Sell
25,801
-1,635
-6% -$300K 0.05% 242
2019
Q1
$5.05M Sell
27,436
-3,084
-10% -$567K 0.06% 215
2018
Q4
$5.06M Sell
30,520
-2,104
-6% -$349K 0.07% 202
2018
Q3
$6.29M Buy
32,624
+1,044
+3% +$201K 0.07% 192
2018
Q2
$5.37M Buy
31,580
+2,400
+8% +$408K 0.06% 208
2018
Q1
$4.76M Buy
29,180
+2,900
+11% +$473K 0.06% 218
2017
Q4
$3.94M Buy
26,280
+600
+2% +$89.9K 0.05% 246
2017
Q3
$3.9M Sell
25,680
-100
-0.4% -$15.2K 0.05% 226
2017
Q2
$3.32M Sell
25,780
-700
-3% -$90.2K 0.05% 245
2017
Q1
$2.9M Buy
26,480
+4,100
+18% +$448K 0.05% 266
2016
Q4
$1.65M Buy
22,380
+1,200
+6% +$88.4K 0.03% 322
2016
Q3
$1.85M Buy
21,180
+1,400
+7% +$122K 0.04% 298
2016
Q2
$1.7M Buy
19,780
+1,500
+8% +$129K 0.04% 294
2016
Q1
$1.45M Buy
18,280
+4,700
+35% +$374K 0.03% 318
2015
Q4
$1.71M Sell
13,580
-18,385
-58% -$2.31M 0.04% 248
2015
Q3
$3.33M Sell
31,965
-20,125
-39% -$2.1M 0.08% 166
2015
Q2
$6.43M Buy
52,090
+9,500
+22% +$1.17M 0.14% 126
2015
Q1
$5.02M Sell
42,590
-13,700
-24% -$1.62M 0.11% 143
2014
Q4
$6.69M Buy
56,290
+1,100
+2% +$131K 0.15% 124
2014
Q3
$6.2M Buy
55,190
+20,110
+57% +$2.26M 0.14% 121
2014
Q2
$3.32M Buy
+35,080
New +$3.32M 0.07% 176
2013
Q4
$4.69M Buy
+63,080
New +$4.69M 0.11% 126